AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

REPLIGEN CORP Director's Dealing 2024

Aug 20, 2024

30826_dirs_2024-08-19_ca28ccfb-4e52-4434-8409-06db084bc9df.zip

Director's Dealing

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2024-06-14

Reporting Person: DAWES KAREN A (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	91123	Direct